Study of Exercise Capacity and Physical Activity in Children With Congenital Heart Disease
Launched by UNIVERSITY OF ULSTER · Apr 17, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a personalized physical activity (PA) plan can help children and teenagers with congenital heart disease (CHD) improve their ability to exercise and participate in physical activities. Congenital heart disease is a common heart condition present at birth, and many children with this condition do not get enough exercise, partly because their parents worry about how activity might affect their health. This study aims to address those concerns by creating tailored exercise plans for each child, which will be shared with both parents and their teachers or coaches. The goal is to help more children with CHD meet the recommended 60 minutes of physical activity each day, ultimately enhancing their overall health and quality of life.
To be eligible for this trial, children aged 5 to 18 with any type of congenital heart disease can participate, including those with an intellectual disability. However, children with additional health conditions that could complicate their participation will not be included. Participants will receive a customized PA plan to follow at home over 12 weeks, along with follow-up support at 3 and 6 months. This study will gather feedback from families and educators to understand the impact of these plans, helping to ensure that children with CHD can safely enjoy physical activities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children with congenital heart disease aged 5-18 years (all diagnoses).
- • Children with congenital heart disease aged 5-18 years and an intellectual disability.
- Exclusion Criteria:
- • Children or parents/guardians who do not wish to give assent or consent to participate in this study.
- • Children with an underlying health condition and or physical disability in addition to congenital heart disease, to minimize the risk of confounding variables.
About University Of Ulster
The University of Ulster is a leading academic institution dedicated to advancing knowledge and innovation through research and education. Renowned for its commitment to excellence, the university actively engages in clinical trials aimed at improving healthcare outcomes and addressing pressing health challenges. With a robust infrastructure for research and a multidisciplinary approach, the University of Ulster fosters collaboration among researchers, healthcare professionals, and industry partners. Its focus on evidence-based practices ensures that clinical trials are designed and conducted to the highest ethical and scientific standards, contributing valuable insights to the field of medicine and enhancing patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Belfast, , United Kingdom
Patients applied
Trial Officials
Professor Casey
Principal Investigator
Ulster University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported